Rapid identification of Coronaviruses including SARS-CoV-2 and detection of its mutations

TECHNOLOGY SUMMARY

Rapid diagnostic assay for the in-field identification of Coronaviruses including SARS-CoV-2 and detection of mutations in its spike protein from human nasal, buccal or saliva samples. It can be used by individuals without medical expertise to provide integrated sample-to-answer process flow in less than 30 minutes.

AREA/MATURITY/AWARDS

Primary Application Area: Healthcare & Medical Devices

Technology Development Status: Prototype

Technology Readiness Level: TRL 6

National Innovation Awardee

SHOWCASE SUMMARY

Organization Type: Mid-stage Startup (A or B)

GOVT/EXTERNAL FUNDING SOURCES